SAFETY AND EFFICACY EXTENSION STUDY OF DACLIZUMAB HIGH YIELD PROCESS (DAC HYP) (BIIB019) IN PARTICIPANTS WHO HAVE COMPLETED STUDY 205MS202 (NCT00870740) TO TREAT RELAPSING REMITTING MULTIPLE SCLEROSIS: